Mansour Al‐Moundhri

2.4k total citations
88 papers, 1.8k citations indexed

About

Mansour Al‐Moundhri is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mansour Al‐Moundhri has authored 88 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Oncology, 24 papers in Molecular Biology and 20 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mansour Al‐Moundhri's work include Gastric Cancer Management and Outcomes (9 papers), Colorectal Cancer Screening and Detection (9 papers) and Global Cancer Incidence and Screening (8 papers). Mansour Al‐Moundhri is often cited by papers focused on Gastric Cancer Management and Outcomes (9 papers), Colorectal Cancer Screening and Detection (9 papers) and Global Cancer Incidence and Screening (8 papers). Mansour Al‐Moundhri collaborates with scholars based in Oman, United Kingdom and United Arab Emirates. Mansour Al‐Moundhri's co-authors include Badreldin H. Ali, Ikram Burney, Mohammed Al‐Azri, Bassim Al Bahrani, Shiyam Kumar, Abderrahim Nemmar, Suhail Al‐Salam, Mostafa I. Waly, Christopher S. Grant and S. S. Ganguly and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Mansour Al‐Moundhri

84 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mansour Al‐Moundhri Oman 24 701 501 467 283 262 88 1.8k
Halcyon G. Skinner United States 24 757 1.1× 533 1.1× 389 0.8× 199 0.7× 272 1.0× 50 1.9k
Adnan Aydıner Türkiye 25 1.0k 1.5× 304 0.6× 272 0.6× 473 1.7× 295 1.1× 156 2.3k
Wing Ming Ho Hong Kong 26 733 1.0× 352 0.7× 250 0.5× 262 0.9× 246 0.9× 42 3.1k
Johanna M.A. Pijnenborg Netherlands 32 801 1.1× 398 0.8× 177 0.4× 262 0.9× 310 1.2× 160 3.1k
Alina Vrieling Netherlands 30 1.1k 1.6× 470 0.9× 449 1.0× 310 1.1× 296 1.1× 70 2.3k
Jane C. Figueiredo United States 24 557 0.8× 414 0.8× 330 0.7× 193 0.7× 188 0.7× 65 1.6k
Kimberly A. Lowe United States 25 569 0.8× 276 0.6× 294 0.6× 231 0.8× 290 1.1× 79 2.0k
Ying Zheng China 28 1.3k 1.8× 383 0.8× 138 0.3× 404 1.4× 346 1.3× 62 2.1k
Mark Powell United States 21 720 1.0× 454 0.9× 167 0.4× 411 1.5× 122 0.5× 52 1.7k
Mison Chun South Korea 28 876 1.2× 292 0.6× 274 0.6× 510 1.8× 269 1.0× 160 2.6k

Countries citing papers authored by Mansour Al‐Moundhri

Since Specialization
Citations

This map shows the geographic impact of Mansour Al‐Moundhri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mansour Al‐Moundhri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mansour Al‐Moundhri more than expected).

Fields of papers citing papers by Mansour Al‐Moundhri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mansour Al‐Moundhri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mansour Al‐Moundhri. The network helps show where Mansour Al‐Moundhri may publish in the future.

Co-authorship network of co-authors of Mansour Al‐Moundhri

This figure shows the co-authorship network connecting the top 25 collaborators of Mansour Al‐Moundhri. A scholar is included among the top collaborators of Mansour Al‐Moundhri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mansour Al‐Moundhri. Mansour Al‐Moundhri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Al‐Moundhri, Mansour, et al.. (2024). Preventing 5-fluorouracil-induced ischemic events in very high-risk cardiac patients: A retrospective cohort analysis (SQCCCRC protocol).. Journal of Clinical Oncology. 42(16_suppl). e24112–e24112. 1 indexed citations
2.
Al‐Moundhri, Mansour, et al.. (2024). Referral Process Enhancement: Innovative Approaches and Best Practices. Asian Pacific Journal of Cancer Prevention. 25(5). 1691–1698.
3.
Omar, Rumana, et al.. (2023). P-204 DPYD gene variants and chemotherapy-induced toxicity in Omani patients with gastrointestinal tumors. Annals of Oncology. 34. S88–S88. 1 indexed citations
4.
Gupta, Ishita, et al.. (2022). SOCS3 gene silencing does not occur through methylation and mutations in gastric cancer. Human Cell. 35(4). 1114–1125. 5 indexed citations
5.
Al‐Moundhri, Mansour, et al.. (2022). Launching of the Sultan Qaboos Comprehensive Cancer Care and Research Center (SQCCCRC) in the Sultanate of Oman to manage HBP type of cancers. HepatoBiliary Surgery and Nutrition. 11(2). 338–339. 3 indexed citations
6.
Burney, Ikram, et al.. (2021). E2F5 Promotes the Malignancy of Ovarian Cancer Via the Regulation of Hippo and Wnt Pathways. Genetic Testing and Molecular Biomarkers. 25(3). 179–186. 5 indexed citations
7.
Kumar, Shiyam, et al.. (2021). Beliefs and Perceptions About Cancer Diagnosis and Treatment-Seeking and Decision-Making Behaviors Among Omani Patients with Cancer: A Single-Center Study. Journal of Religion and Health. 61(2). 1351–1365. 7 indexed citations
9.
Naik, Adviti, et al.. (2019). Neoadjuvant Chemotherapy Alters Neuropilin-1, PlGF, and SNAI1 Expression Levels and Predicts Breast Cancer Patients Response. Frontiers in Oncology. 9. 323–323. 12 indexed citations
10.
Gupta, Ishita, Ikram Burney, Mansour Al‐Moundhri, & Yahya Tamimi. (2017). Molecular genetics complexity impeding research progress in breast and ovarian cancers. Molecular and Clinical Oncology. 7(1). 3–14. 12 indexed citations
11.
Tamimi, Yahya, et al.. (2014). The p53 Mutation / Deletion Profile in a Small Cohort of the Omani Population with Diffuse Large B-Cell Lymphoma. Sultan Qaboos University medical journal. 14(1). 50–58. 3 indexed citations
12.
Ali, Amanat, et al.. (2013). Dietary and Lifestyle Factors and Risk of Non-Hodgkin's Lymphoma in Oman. Asian Pacific Journal of Cancer Prevention. 14(2). 841–848. 21 indexed citations
13.
Al‐Moundhri, Mansour, et al.. (2012). The Effect of Curcumin on Oxaliplatin and Cisplatin Neurotoxicity in Rats: Some Behavioral, Biochemical, and Histopathological Studies. Journal of Medical Toxicology. 9(1). 25–33. 101 indexed citations
14.
Al‐Azri, Mohammed, et al.. (2009). Coping With a Diagnosis of Breast Cancer-Literature Review and Implications for Developing Countries. The Breast Journal. 15(6). 615–622. 96 indexed citations
15.
Burney, Ikram & Mansour Al‐Moundhri. (2008). Major Advances in the Treatment of Cancer: What does a Non-Oncologist need to know?. PubMed Central. 7 indexed citations
16.
Ali, Badreldin H., et al.. (2008). Ontogenic aspects of cisplatin-induced nephrotoxicity in rats. Food and Chemical Toxicology. 46(11). 3355–3359. 33 indexed citations
17.
Al‐Moundhri, Mansour. (2007). NAT2polymorphism in Omani gastric cancer patients-risk predisposition and clinicopathological associations. World Journal of Gastroenterology. 13(19). 2697–2697. 13 indexed citations
18.
Burney, Ikram, V Nirmala, Mansour Al‐Moundhri, & Nicholas Woodhouse. (2007). Nodular Lymphocyte Predominant Hodgkin’s Lymphoma Presenting as Severe Hypercalcaemia: A Case Report. Sultan Qaboos University medical journal. 7(3). 247–251.
19.
Ali, Badreldin H. & Mansour Al‐Moundhri. (2006). Agents ameliorating or augmenting the nephrotoxicity of cisplatin and other platinum compounds: A review of some recent research. Food and Chemical Toxicology. 44(8). 1173–1183. 267 indexed citations
20.
Al‐Moundhri, Mansour, et al.. (1998). Immunotherapy in lung cancer. British Journal of Cancer. 78(3). 282–288. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026